首页 > 最新文献

Canadian Journal of Infectious Diseases & Medical Microbiology最新文献

英文 中文
Polymorphism of E6 and E7 Genes in Human Papillomavirus Types 31 and 33 in Northeast China. 东北地区31型和33型人乳头瘤病毒E6和E7基因多态性分析
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1155/2023/9338294
Miao Yu, Si Wu, Shuang Wang, Changwan Cui, Yiping Lu, Zhengrong Sun

Persistent infection with human papillomavirus (HPV) types 31 and 33 is an important causative factor for cervical cancer. The E6/E7 genes are key oncogenes involved in the immortalization and transformation of human epithelial cells. Genetic polymorphism may lead to differences in the virus' carcinogenic potential, the immune reaction of the host, and the potencies of vaccines. Few studies on HPV31/33 E6/E7 genetic polymorphism have been carried out. To study the genetic polymorphism of HPV31 and HPV33 E6/E7 genes in northeast China, these genes (HPV31 E6/E7, n = 151; HPV33 E6/E7, n = 136) were sequenced and compared to reference sequences (J04353.1, M12732.1) using BioEdit. Phylogenetic trees were constructed by the neighbor-joining method using MegaX. The diversity of the secondary structure was estimated using the PSIPred server. The positively selected sites were analyzed using PAML4.9. The major histocompatibility complex (MHC) class I and MHCII epitopes were predicted using the ProPred-I server and ProPredserver. B-cell epitopes were predicted using the ABCpred server. In the 151 HPV31E6 sequences, 25 (25/450) single-nucleotide mutations were found, 14 of which were synonymous mutations and 11 were nonsynonymous. In the 151 HPV31E7 sequences, 8 (8/297) nucleotide mutations were found, 3 of which were synonymous mutations and 5 were nonsynonymous. In the 136 HPV33E6 sequences, 17 (17/450) nucleotide mutations were observed, 7 of which were synonymous mutations and 10 were nonsynonymous. C14T/G (T5I/S) was a triallelic mutation. Finally, in the 136 HPV33E7 sequences, 9 (9/294) nucleotide mutations were observed, 3 of which were synonymous mutations and 6 were nonsynonymous. C134T/A (A45V/E) and C278G/A (T93S/N) were triallelic mutations. Lineage A was the most common lineage in both HPV31 and HPV33. In all of the sequences, we only identified one positively selected site, HPV33 E6 (K93N). Most nonsynonymous mutations were localized at sites belonging to MHC and/or B-cell predicted epitopes. Data obtained in this study should contribute to the development and application of detection probes, targeted drugs, and vaccines.

人乳头瘤病毒(HPV) 31型和33型的持续感染是宫颈癌的重要致病因素。E6/E7基因是参与人上皮细胞永生化和转化的关键癌基因。基因多态性可能导致病毒致癌性、宿主免疫反应和疫苗效力的差异。对hpv31 / 33e6 /E7基因多态性的研究较少。为了研究东北地区HPV31和HPV33 E6/E7基因的遗传多态性,这些基因(HPV31 E6/E7, n = 151;HPV33 E6/E7, n = 136)测序,并与参考序列(J04353.1, M12732.1)进行比对。利用MegaX软件,采用邻居联接法构建系统发育树。使用PSIPred服务器估计二级结构的多样性。使用PAML4.9对阳性选择位点进行分析。使用ProPred-I和ProPredserver预测主要组织相容性复合体(MHC) I类和MHCII表位。使用ABCpred服务器预测b细胞表位。在151个HPV31E6序列中,共发现25个(25/450)单核苷酸突变,其中14个为同义突变,11个为非同义突变。在151条HPV31E7序列中,共发现8(8/297)个核苷酸突变,其中3个为同义突变,5个为非同义突变。136条HPV33E6序列共检测到17(17/450)个核苷酸突变,其中同义突变7个,非同义突变10个。C14T/G (T5I/S)是一个三等位基因突变。136条HPV33E7序列共检测到9(9/294)个核苷酸突变,其中3个为同义突变,6个为非同义突变。C134T/A (A45V/E)和C278G/A (T93S/N)为试验等位基因突变。谱系A是HPV31和HPV33中最常见的谱系。在所有序列中,我们只鉴定出一个阳性选择位点,HPV33 E6 (K93N)。大多数非同义突变定位在属于MHC和/或b细胞预测表位的位置。本研究获得的数据将有助于检测探针、靶向药物和疫苗的开发和应用。
{"title":"Polymorphism of E6 and E7 Genes in Human Papillomavirus Types 31 and 33 in Northeast China.","authors":"Miao Yu,&nbsp;Si Wu,&nbsp;Shuang Wang,&nbsp;Changwan Cui,&nbsp;Yiping Lu,&nbsp;Zhengrong Sun","doi":"10.1155/2023/9338294","DOIUrl":"https://doi.org/10.1155/2023/9338294","url":null,"abstract":"<p><p>Persistent infection with human papillomavirus (HPV) types 31 and 33 is an important causative factor for cervical cancer. The E6/E7 genes are key oncogenes involved in the immortalization and transformation of human epithelial cells. Genetic polymorphism may lead to differences in the virus' carcinogenic potential, the immune reaction of the host, and the potencies of vaccines. Few studies on HPV31/33 E6/E7 genetic polymorphism have been carried out. To study the genetic polymorphism of HPV31 and HPV33 E6/E7 genes in northeast China, these genes (HPV31 E6/E7, <i>n</i> = 151; HPV33 E6/E7, <i>n</i> = 136) were sequenced and compared to reference sequences (J04353.1, M12732.1) using BioEdit. Phylogenetic trees were constructed by the neighbor-joining method using MegaX. The diversity of the secondary structure was estimated using the PSIPred server. The positively selected sites were analyzed using PAML4.9. The major histocompatibility complex (MHC) class I and MHCII epitopes were predicted using the ProPred-I server and ProPredserver. B-cell epitopes were predicted using the ABCpred server. In the 151 HPV31E6 sequences, 25 (25/450) single-nucleotide mutations were found, 14 of which were synonymous mutations and 11 were nonsynonymous. In the 151 HPV31E7 sequences, 8 (8/297) nucleotide mutations were found, 3 of which were synonymous mutations and 5 were nonsynonymous. In the 136 HPV33E6 sequences, 17 (17/450) nucleotide mutations were observed, 7 of which were synonymous mutations and 10 were nonsynonymous. C14T/G (T5I/S) was a triallelic mutation. Finally, in the 136 HPV33E7 sequences, 9 (9/294) nucleotide mutations were observed, 3 of which were synonymous mutations and 6 were nonsynonymous. C134T/A (A45V/E) and C278G/A (T93S/N) were triallelic mutations. Lineage A was the most common lineage in both HPV31 and HPV33. In all of the sequences, we only identified one positively selected site, HPV33 E6 (K93N). Most nonsynonymous mutations were localized at sites belonging to MHC and/or B-cell predicted epitopes. Data obtained in this study should contribute to the development and application of detection probes, targeted drugs, and vaccines.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2023 ","pages":"9338294"},"PeriodicalIF":2.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9219753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidrug-Resistant Pathogens in Burn Wound, Prevention, Diagnosis, and Therapeutic Approaches (Conventional Antimicrobials and Nanoparticles). 烧伤创面耐多药病原体,预防,诊断和治疗方法(常规抗菌剂和纳米颗粒)。
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1155/2023/8854311
Jaber Hemmati, Mehdi Azizi, Babak Asghari, Mohammad Reza Arabestani

Multidrug-resistant pathogens are one of the common causes of death in burn patients and have a high risk of nosocomial infections, especially pneumonia, urinary tract infections, and cellulitis. The role of prolonged hospitalization and empirical antibiotics administration in developing multidrug-resistant pathogens is undeniable. In the early days of admitting burn patients, Gram-positive bacteria were the dominant isolates with a more sensitive antibiotic pattern. However, the emergence of Gram-negative bacteria that are more resistant later occurs. Trustworthy guideline administration in burn wards is one of the strategies to prevent multidrug-resistant pathogens. Also, a multidisciplinary therapeutic approach is an effective way to avoid antibiotic resistance that involves infectious disease specialists, pharmacists, and burn surgeons. However, the emerging resistance to conventional antimicrobial approaches (such as systemic antibiotic exposure, traditional wound dressing, and topical antibiotic ointments) among burn patients has challenged the treatment of multidrug-resistant infections, and using nanoparticles is a suitable alternative. In this review article, we will discuss different aspects of multidrug-resistant pathogens in burn wounds, emphasizing the full role of these pathogens in burn wounds and discussing the application of nanotechnology in dealing with them. Also, some advances in various types of nanomaterials, including metallic nanoparticles, liposomes, hydrogels, carbon quantum dots, and solid lipid nanoparticles in burn wound healing, will be explained.

耐多药病原体是烧伤患者死亡的常见原因之一,并且具有院内感染的高风险,特别是肺炎、尿路感染和蜂窝织炎。长期住院和经验性抗生素给药在产生多重耐药病原体中的作用是不可否认的。在入院烧伤患者的早期,革兰氏阳性菌是主要的分离株,具有更敏感的抗生素模式。然而,革兰氏阴性菌的出现在之后会产生更强的耐药性。烧伤病房可靠的指南管理是预防耐多药病原菌的策略之一。此外,多学科治疗方法是避免抗生素耐药性的有效途径,涉及传染病专家,药剂师和烧伤外科医生。然而,烧伤患者对传统抗菌素方法(如全身抗生素暴露、传统伤口敷料和局部抗生素软膏)的耐药性的出现对多药耐药感染的治疗提出了挑战,使用纳米颗粒是一种合适的替代方案。在这篇综述文章中,我们将讨论烧伤创面中耐多药病原体的不同方面,强调这些病原体在烧伤创面中的全部作用,并讨论纳米技术在治疗这些病原体中的应用。此外,还将介绍各种类型的纳米材料,包括金属纳米颗粒、脂质体、水凝胶、碳量子点和固体脂质纳米颗粒在烧伤创面愈合中的一些进展。
{"title":"Multidrug-Resistant Pathogens in Burn Wound, Prevention, Diagnosis, and Therapeutic Approaches (Conventional Antimicrobials and Nanoparticles).","authors":"Jaber Hemmati,&nbsp;Mehdi Azizi,&nbsp;Babak Asghari,&nbsp;Mohammad Reza Arabestani","doi":"10.1155/2023/8854311","DOIUrl":"https://doi.org/10.1155/2023/8854311","url":null,"abstract":"<p><p>Multidrug-resistant pathogens are one of the common causes of death in burn patients and have a high risk of nosocomial infections, especially pneumonia, urinary tract infections, and cellulitis. The role of prolonged hospitalization and empirical antibiotics administration in developing multidrug-resistant pathogens is undeniable. In the early days of admitting burn patients, Gram-positive bacteria were the dominant isolates with a more sensitive antibiotic pattern. However, the emergence of Gram-negative bacteria that are more resistant later occurs. Trustworthy guideline administration in burn wards is one of the strategies to prevent multidrug-resistant pathogens. Also, a multidisciplinary therapeutic approach is an effective way to avoid antibiotic resistance that involves infectious disease specialists, pharmacists, and burn surgeons. However, the emerging resistance to conventional antimicrobial approaches (such as systemic antibiotic exposure, traditional wound dressing, and topical antibiotic ointments) among burn patients has challenged the treatment of multidrug-resistant infections, and using nanoparticles is a suitable alternative. In this review article, we will discuss different aspects of multidrug-resistant pathogens in burn wounds, emphasizing the full role of these pathogens in burn wounds and discussing the application of nanotechnology in dealing with them. Also, some advances in various types of nanomaterials, including metallic nanoparticles, liposomes, hydrogels, carbon quantum dots, and solid lipid nanoparticles in burn wound healing, will be explained.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2023 ","pages":"8854311"},"PeriodicalIF":2.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10267887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnosis of Acute Dengue Virus Infection Using Enzyme-Linked Immunosorbent Assay and Real-Time PCR. 应用酶联免疫吸附试验和实时荧光定量PCR诊断急性登革病毒感染。
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1155/2023/3995366
Gohar Iqbal, Hasnain Javed, Faiz Ahmed Raza, Umar Farooq Gohar, Warda Fatima, Mohsin Khurshid

Dengue fever is a viral infection caused by the dengue virus and is a growing concern for public health worldwide, particularly in tropical and subtropical regions. This study aimed to assess the diagnostic accuracy of a commercially available NS1 ELISA kit for dengue fever in Pakistan using multiplex qRT-PCR as the gold standard. The study recruited 1236 suspected cases of dengue fever admitted to public sector hospitals in Lahore, Pakistan. Of the suspected cases, 610 (49.3%) were confirmed positive for DENV infection through qRT-PCR, with all four serotypes detected. DENV-2 was the most prevalent serotype, detected in 95.7% of cases. The NS1 ELISA kit detected 71.1% of the positive cases. However, the diagnostic accuracy of the NS1 ELISA kit was found to be only 64.89%. Of the 610 confirmed cases, 68% were male and 32% were female, with a median age of 30 years. Dengue fever was diagnosed in 91.8% of cases, while 8.2% were diagnosed with dengue hemorrhagic fever (DHF). DHF patients had a higher prevalence of abdominal pain, hemorrhagic manifestations, and thrombocytopenia. The cocirculation of all four DENV serotypes in Lahore is concerning and could lead to more severe forms of the disease, such as DHF or dengue shock syndrome, in the future. The study highlights the low diagnostic accuracy of commercially available NS1 ELISA kits and emphasizes the importance of using molecular methods to confirm acute dengue infections. Given the increasing prevalence of dengue fever in developing countries like Pakistan, more accurate and reliable diagnostic tools are needed for effective disease management and control.

登革热是一种由登革热病毒引起的病毒性感染,是全球公共卫生日益关注的问题,特别是在热带和亚热带地区。本研究旨在评估巴基斯坦市售的NS1 ELISA试剂盒对登革热的诊断准确性,该试剂盒使用多重qRT-PCR作为金标准。该研究招募了巴基斯坦拉合尔公立医院收治的1236例登革热疑似病例。在疑似病例中,通过qRT-PCR确诊DENV感染阳性610例(49.3%),检测到所有4种血清型。DENV-2是最常见的血清型,在95.7%的病例中检测到。NS1 ELISA试剂盒检测阳性率为71.1%。而NS1 ELISA试剂盒的诊断准确率仅为64.89%。在610例确诊病例中,68%为男性,32%为女性,中位年龄为30岁。91.8%的病例诊断为登革热,8.2%的病例诊断为登革出血热。DHF患者腹痛、出血和血小板减少的发生率较高。拉合尔所有四种登革出血热血清型的共同流行令人担忧,并可能在未来导致更严重的疾病形式,如登革出血热或登革休克综合征。该研究强调了市售NS1 ELISA试剂盒的诊断准确性较低,并强调了使用分子方法确认急性登革热感染的重要性。鉴于登革热在巴基斯坦等发展中国家日益流行,需要更准确和可靠的诊断工具来进行有效的疾病管理和控制。
{"title":"Diagnosis of Acute Dengue Virus Infection Using Enzyme-Linked Immunosorbent Assay and Real-Time PCR.","authors":"Gohar Iqbal,&nbsp;Hasnain Javed,&nbsp;Faiz Ahmed Raza,&nbsp;Umar Farooq Gohar,&nbsp;Warda Fatima,&nbsp;Mohsin Khurshid","doi":"10.1155/2023/3995366","DOIUrl":"https://doi.org/10.1155/2023/3995366","url":null,"abstract":"<p><p>Dengue fever is a viral infection caused by the dengue virus and is a growing concern for public health worldwide, particularly in tropical and subtropical regions. This study aimed to assess the diagnostic accuracy of a commercially available NS1 ELISA kit for dengue fever in Pakistan using multiplex qRT-PCR as the gold standard. The study recruited 1236 suspected cases of dengue fever admitted to public sector hospitals in Lahore, Pakistan. Of the suspected cases, 610 (49.3%) were confirmed positive for DENV infection through qRT-PCR, with all four serotypes detected. DENV-2 was the most prevalent serotype, detected in 95.7% of cases. The NS1 ELISA kit detected 71.1% of the positive cases. However, the diagnostic accuracy of the NS1 ELISA kit was found to be only 64.89%. Of the 610 confirmed cases, 68% were male and 32% were female, with a median age of 30 years. Dengue fever was diagnosed in 91.8% of cases, while 8.2% were diagnosed with dengue hemorrhagic fever (DHF). DHF patients had a higher prevalence of abdominal pain, hemorrhagic manifestations, and thrombocytopenia. The cocirculation of all four DENV serotypes in Lahore is concerning and could lead to more severe forms of the disease, such as DHF or dengue shock syndrome, in the future. The study highlights the low diagnostic accuracy of commercially available NS1 ELISA kits and emphasizes the importance of using molecular methods to confirm acute dengue infections. Given the increasing prevalence of dengue fever in developing countries like Pakistan, more accurate and reliable diagnostic tools are needed for effective disease management and control.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2023 ","pages":"3995366"},"PeriodicalIF":2.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9923155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First Evidence of Fowl Adenovirus Induced Inclusion Body Hepatitis in Chicken in Bangladesh. 家禽腺病毒在孟加拉国引起鸡包涵体肝炎的第一个证据。
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1155/2023/7253433
Mohammad Nazrul Islam, Md Mostafizer Rahman, Md Khalesur Rahman, Jahangir Alam

Background: The livestock sector contributes 1.90% to the GDP in Bangladesh during 2021-22. Poultry is one of the important subsectors struggling with diseases. Fowl adenoviruses (FAdVs) cause numerous diseases resulting in economic losses to the poultry industry worldwide. Several FAdV serotypes cause inclusion body hepatitis in chicken. Although FAdV infection was suspected, there was no confirmatory report from Bangladesh. The study was conducted to investigate the FAdV infection and antibodies in chicken.

Methods: A total of 50 samples, each composed of liver and spleen, were collected from different chickens of Gazipur, Dinajpur, and Panchagarh district. Each location belongs to A, B, and C poultry zones of Bangladesh, respectively. Viruses were detected by real-time PCR and conventional PCR. Blood samples (n = 303) were collected at the beginning and after the recovery from infection and tested by indirect ELISA. Sequencing of PCR products was done for serotyping and phylogenetic analysis.

Results: Clinical signs were observed including anorexia, drowsiness, ruffled feathers, reduced body weight, lack of uniformity, and high mortality (15-25%). Enlarged friable liver with yellow to tan color mottled with the focal soft area, fluid in pericardial sac, swollen and hemorrhagic kidneys, enlarged congested spleen and pancreas, etc. were found on postmortem examination. FAdVs were detected in 90% of the flocks except commercial layer flock from Dinajpur. Three serotypes, namely, 8b (70%), 11 (10%), and 5 (10%) were detected. Anti-FAdV antibody was detected in 80% flocks at the beginning of infection and in 90% of the flocks after recovery from infection. The antibody titer increases significantly (p < 0.05) after recovery from infection. Phylogenetic analysis revealed that the Bangladeshi FAdVs have close identity with viruses from Asia, Europe, and South and North America.

Conclusions: These findings suggested that several introductions of FAdVs were taken place in Bangladesh. To combat the disease, vaccination along with maintenance of biosecurity is essential.

背景:2021- 2022年期间,畜牧业对孟加拉国国内生产总值的贡献为1.90%。家禽是与疾病作斗争的重要分部门之一。禽腺病毒(FAdVs)引起多种疾病,给世界范围内的家禽业造成经济损失。几种FAdV血清型可引起鸡包涵体肝炎。虽然怀疑有FAdV感染,但孟加拉国没有确认性报告。本研究旨在研究FAdV在鸡体内的感染情况及其抗体。方法:选取加济布尔、迪纳杰布尔和潘恰加尔地区不同类型鸡的肝脏和脾脏各50份。每个地点分别属于孟加拉国的A、B和C家禽区。采用实时荧光定量PCR和常规荧光定量PCR检测病毒。分别于感染开始及痊愈后采集血样303例,采用间接ELISA法检测。PCR产物测序进行血清分型和系统发育分析。结果:临床表现为厌食、嗜睡、羽毛起皱、体重减轻、不均匀、死亡率高(15-25%)。死后见肝肿大易碎,黄至棕褐色,伴病灶软区,心包囊积液,肾肿胀出血,脾、胰肿大充血等。除Dinajpur市商品蛋鸡群外,90%的鸡群检测到FAdVs。检测到8b(70%)、11(10%)和5(10%)3种血清型。感染初期80%的鸡群检测到抗fadv抗体,感染恢复后90%的鸡群检测到抗fadv抗体。感染痊愈后抗体滴度显著升高(p < 0.05)。系统发育分析显示,孟加拉国的口蹄疫病毒与来自亚洲、欧洲、南美和北美的病毒具有密切的同一性。结论:这些发现表明,孟加拉国发生了几次fadv的传入。为了防治这种疾病,接种疫苗和维持生物安全至关重要。
{"title":"First Evidence of Fowl Adenovirus Induced Inclusion Body Hepatitis in Chicken in Bangladesh.","authors":"Mohammad Nazrul Islam,&nbsp;Md Mostafizer Rahman,&nbsp;Md Khalesur Rahman,&nbsp;Jahangir Alam","doi":"10.1155/2023/7253433","DOIUrl":"https://doi.org/10.1155/2023/7253433","url":null,"abstract":"<p><strong>Background: </strong>The livestock sector contributes 1.90% to the GDP in Bangladesh during 2021-22. Poultry is one of the important subsectors struggling with diseases. Fowl adenoviruses (FAdVs) cause numerous diseases resulting in economic losses to the poultry industry worldwide. Several FAdV serotypes cause inclusion body hepatitis in chicken. Although FAdV infection was suspected, there was no confirmatory report from Bangladesh. The study was conducted to investigate the FAdV infection and antibodies in chicken.</p><p><strong>Methods: </strong>A total of 50 samples, each composed of liver and spleen, were collected from different chickens of Gazipur, Dinajpur, and Panchagarh district. Each location belongs to A, B, and C poultry zones of Bangladesh, respectively. Viruses were detected by real-time PCR and conventional PCR. Blood samples (<i>n</i> = 303) were collected at the beginning and after the recovery from infection and tested by indirect ELISA. Sequencing of PCR products was done for serotyping and phylogenetic analysis.</p><p><strong>Results: </strong>Clinical signs were observed including anorexia, drowsiness, ruffled feathers, reduced body weight, lack of uniformity, and high mortality (15-25%). Enlarged friable liver with yellow to tan color mottled with the focal soft area, fluid in pericardial sac, swollen and hemorrhagic kidneys, enlarged congested spleen and pancreas, etc. were found on postmortem examination. FAdVs were detected in 90% of the flocks except commercial layer flock from Dinajpur. Three serotypes, namely, 8b (70%), 11 (10%), and 5 (10%) were detected. Anti-FAdV antibody was detected in 80% flocks at the beginning of infection and in 90% of the flocks after recovery from infection. The antibody titer increases significantly (<i>p</i> < 0.05) after recovery from infection. Phylogenetic analysis revealed that the Bangladeshi FAdVs have close identity with viruses from Asia, Europe, and South and North America.</p><p><strong>Conclusions: </strong>These findings suggested that several introductions of FAdVs were taken place in Bangladesh. To combat the disease, vaccination along with maintenance of biosecurity is essential.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2023 ","pages":"7253433"},"PeriodicalIF":2.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9091783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tracing the Negative Results of Multiplex Real-Time PCR Assay for Diagnosis of Bacterial Pediatrics Meningitis. 多重实时荧光定量PCR法诊断细菌性儿科脑膜炎阴性结果的追踪。
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1155/2023/3502666
Abdollah Karimi, Sedigheh Rafiei Tabatabaei, Leila Azimi, Nasim Almasian Tehrani, Fatemeh Fallah, Iman Faghihian

The death because of meningitis remains high in some parts of the world. It is important to know the specific cause of meningitis because the treatment differs depending on the cause. This study aimed to trace the false-negative results of multiplex RT-PCR to detect Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis serogroup by two different molecular methods. In this study, the CSF of the suspicious pediatric for acute bacterial meningitis among children aged 1 month to 14 years who are admitted to the hospitals in four cities of a certain region of Iran was collected. S. pneumoniae, H. influenzae, and N. meningitidis in CSF samples were detected by single-tube multiplex RT-PCR and specific RT-PCR with a probe on the same specimens. In this cross-sectional study, 506 CSF samples were collected during one year. The multiplex RT-PCR can detect 3.3% and 2.2% of S. pneumoniae and H. influenzae, respectively. N. meningitidis was not detected. The CSF analysis was abnormal in 53% of 506 patients. On the other hand, 11.5%, 4.8%, and 4.1% of S. pneumoniae, H. influenzae, and N. meningitidis were identified, respectively, by specific RT-PCR assay, exactly on the same specimens. Various types of PCR can be used for pathogen identification. As we change the type of PCR in our study, we could approximately increase 15% our positive results and also consequently decrease our false-negative responses.

在世界某些地区,脑膜炎的死亡率仍然很高。了解脑膜炎的具体病因是很重要的,因为治疗方法因病因而异。本研究旨在通过两种不同的分子方法追踪多重RT-PCR检测肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌血清组的假阴性结果。本研究收集了伊朗某地区4个城市医院收治的1个月至14岁儿童疑似急性细菌性脑膜炎患儿的脑脊液。采用单管多重RT-PCR和带探针的特异性RT-PCR检测脑脊液样本中的肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌。在这项横断面研究中,在一年内收集了506份脑脊液样本。多重RT-PCR检测肺炎链球菌和流感嗜血杆菌的阳性率分别为3.3%和2.2%。未检出脑膜炎奈瑟菌。506例患者中有53%的脑脊液分析异常。另一方面,通过特异性RT-PCR方法,在同一标本上分别鉴定出11.5%、4.8%和4.1%的肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌。多种类型的PCR可用于病原体鉴定。当我们在研究中改变PCR的类型时,我们可以大约增加15%的阳性结果,从而减少假阴性反应。
{"title":"Tracing the Negative Results of Multiplex Real-Time PCR Assay for Diagnosis of Bacterial Pediatrics Meningitis.","authors":"Abdollah Karimi,&nbsp;Sedigheh Rafiei Tabatabaei,&nbsp;Leila Azimi,&nbsp;Nasim Almasian Tehrani,&nbsp;Fatemeh Fallah,&nbsp;Iman Faghihian","doi":"10.1155/2023/3502666","DOIUrl":"https://doi.org/10.1155/2023/3502666","url":null,"abstract":"<p><p>The death because of meningitis remains high in some parts of the world. It is important to know the specific cause of meningitis because the treatment differs depending on the cause. This study aimed to trace the false-negative results of multiplex RT-PCR to detect <i>Streptococcus pneumoniae</i>, <i>Haemophilus influenzae</i>, and <i>Neisseria meningitidis</i> serogroup by two different molecular methods. In this study, the CSF of the suspicious pediatric for acute bacterial meningitis among children aged 1 month to 14 years who are admitted to the hospitals in four cities of a certain region of Iran was collected. <i>S. pneumoniae</i>, <i>H. influenzae</i>, and <i>N. meningitidis</i> in CSF samples were detected by single-tube multiplex RT-PCR and specific RT-PCR with a probe on the same specimens. In this cross-sectional study, 506 CSF samples were collected during one year. The multiplex RT-PCR can detect 3.3% and 2.2% of <i>S. pneumoniae</i> and <i>H. influenzae</i>, respectively. <i>N. meningitidis</i> was not detected. The CSF analysis was abnormal in 53% of 506 patients. On the other hand, 11.5%, 4.8%, and 4.1% of <i>S. pneumoniae</i>, <i>H. influenzae</i>, and <i>N. meningitidis</i> were identified, respectively, by specific RT-PCR assay, exactly on the same specimens. Various types of PCR can be used for pathogen identification. As we change the type of PCR in our study, we could approximately increase 15% our positive results and also consequently decrease our false-negative responses.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2023 ","pages":"3502666"},"PeriodicalIF":2.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10677160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health Behaviours among Travellers Regarding Risk Compensation Following COVID-19 Vaccination in Taizhou, China. 泰州市旅行者在COVID-19疫苗接种后的健康行为与风险补偿
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1155/2023/1329291
Meng-Ge Yang, Li-Jun Wang, Lu-Yin Xu, Mang Ke, Liang-Xue Sun

Background: During the COVID-19 pandemic, public transport was restricted in many countries because of the transmission risk. According to the risk compensation theory, travellers post-COVID-19 vaccination may encounter higher risks; however, no real-world studies provide such evidence. Therefore, we conducted a survey to assess whether risk compensation would occur among travellers' health-related behaviours after COVID-19 vaccination, potentially aggravating the transmission of the virus.

Materials and methods: A self-administered online survey was designed and distributed over WeChat to identify the difference in health behaviours before and after COVID-19 vaccination among travellers at a train station in Taizhou, China, from 13 February to 26 April 2022.

Results: A total of 602 individuals completed the questionnaire. The results revealed no statistical difference between the health behaviours reported by the vaccinated and unvaccinated groups. Participants who received the first dose of the vaccine earlier showed no statistical difference in harmful health behaviours (hand washing frequency decreased by 4.1% (P=0.145) and the duration of public transport travel increased by 3.4% (P=0.437)), but showed better protective health behaviours (mask-wearing duration increased by 24.7% (P=0.014)). Compared to those vaccinated less than three times, participants vaccinated against COVID-19 three times showed no statistical differences in harmful health behaviours mask-wearing duration decreased by 7.0% (P=0.927), their hand washing frequency decreased by 4.8% (P=0.905), and the duration of public transport travel increased by 2.5% (P=0.287). After vaccination, when compared to themselves before vaccination, participants exhibited better health behaviours (increased hand washing frequency and mask-wearing duration, and decreased duration of public transport travel) to some extent.

Conclusion: In conclusion, this study found no evidence of risk compensation among travellers. After being vaccinated, health behaviours partly improved among travellers.

背景:在2019冠状病毒病大流行期间,由于存在传播风险,许多国家限制了公共交通。根据风险补偿理论,接种covid -19疫苗后的旅行者可能面临更高的风险;然而,没有现实世界的研究提供这样的证据。因此,我们进行了一项调查,以评估在COVID-19疫苗接种后旅行者的健康相关行为是否会发生风险补偿,从而可能加剧病毒的传播。材料和方法:设计了一项自我管理的在线调查,并通过微信进行分发,以确定2022年2月13日至4月26日在中国台州一个火车站的旅行者在接种COVID-19疫苗前后健康行为的差异。结果:共602人完成问卷调查。结果显示,接种疫苗组和未接种疫苗组报告的健康行为之间没有统计学差异。较早接种第一剂疫苗的参与者在有害健康行为方面没有统计学差异(洗手频率减少4.1% (P=0.145),乘坐公共交通工具的时间增加3.4% (P=0.437)),但表现出更好的防护健康行为(戴口罩的时间增加24.7% (P=0.014))。与接种三次以下的人群相比,接种三次疫苗的人群有害健康行为无统计学差异,佩戴口罩时间减少7.0% (P=0.927),洗手次数减少4.8% (P=0.905),乘坐公共交通工具的时间增加2.5% (P=0.287)。接种疫苗后,与接种前相比,参与者在一定程度上表现出更好的健康行为(洗手频率和戴口罩时间增加,乘坐公共交通工具的时间减少)。结论:本研究没有发现旅行者进行风险补偿的证据。接种疫苗后,旅行者的健康行为得到部分改善。
{"title":"Health Behaviours among Travellers Regarding Risk Compensation Following COVID-19 Vaccination in Taizhou, China.","authors":"Meng-Ge Yang,&nbsp;Li-Jun Wang,&nbsp;Lu-Yin Xu,&nbsp;Mang Ke,&nbsp;Liang-Xue Sun","doi":"10.1155/2023/1329291","DOIUrl":"https://doi.org/10.1155/2023/1329291","url":null,"abstract":"<p><strong>Background: </strong>During the COVID-19 pandemic, public transport was restricted in many countries because of the transmission risk. According to the risk compensation theory, travellers post-COVID-19 vaccination may encounter higher risks; however, no real-world studies provide such evidence. Therefore, we conducted a survey to assess whether risk compensation would occur among travellers' health-related behaviours after COVID-19 vaccination, potentially aggravating the transmission of the virus.</p><p><strong>Materials and methods: </strong>A self-administered online survey was designed and distributed over WeChat to identify the difference in health behaviours before and after COVID-19 vaccination among travellers at a train station in Taizhou, China, from 13 February to 26 April 2022.</p><p><strong>Results: </strong>A total of 602 individuals completed the questionnaire. The results revealed no statistical difference between the health behaviours reported by the vaccinated and unvaccinated groups. Participants who received the first dose of the vaccine earlier showed no statistical difference in harmful health behaviours (hand washing frequency decreased by 4.1% (<i>P</i>=0.145) and the duration of public transport travel increased by 3.4% (<i>P</i>=0.437)), but showed better protective health behaviours (mask-wearing duration increased by 24.7% (<i>P</i>=0.014)). Compared to those vaccinated less than three times, participants vaccinated against COVID-19 three times showed no statistical differences in harmful health behaviours mask-wearing duration decreased by 7.0% (<i>P</i>=0.927), their hand washing frequency decreased by 4.8% (<i>P</i>=0.905), and the duration of public transport travel increased by 2.5% (<i>P</i>=0.287). After vaccination, when compared to themselves before vaccination, participants exhibited better health behaviours (increased hand washing frequency and mask-wearing duration, and decreased duration of public transport travel) to some extent.</p><p><strong>Conclusion: </strong>In conclusion, this study found no evidence of risk compensation among travellers. After being vaccinated, health behaviours partly improved among travellers.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2023 ","pages":"1329291"},"PeriodicalIF":2.8,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9424450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Epidemiology, Disease Severity and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Viruses Coinfection Seen at Egypt Integrated Acute Respiratory Infections Surveillance, 2020-2022. 2020-2022 年埃及急性呼吸道感染综合监测中发现的严重急性呼吸道综合征冠状病毒 2 和流感病毒合并感染的流行病学、疾病严重程度和结果。
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2022-11-17 eCollection Date: 2022-01-01 DOI: 10.1155/2022/7497500
Manal Fahim, Wael H Roshdy, Ola Deghedy, Reham Kamel, Amel Naguib, Shymaa Showky, Nancy Elguindy, Mohammad Abdel Fattah, Salma Afifi, Amira Mohsen, Amr Kandeel, Khaled Abdelghaffar

Background: Cocirculation of influenza (Flu) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (SARS-CoV-2/Flu) represent a public health concern as it may worsen the severity and increase fatality from coronavirus disease 2019. An increase in the number of patients with coinfection was recently reported. We studied epidemiology, severity, and outcome of patients with SARS-CoV-2/Flu coinfection seen at Egypt's integrated acute respiratory infections surveillance to better describe disease impact and guide effective preventive measures.

Methods: The first two outpatients were seen daily, and every fifth patient admitted to 19 sentinel hospitals with respiratory symptoms was enrolled. Patients were interviewed using a standardized questionnaire and provided nasopharyngeal swabs to be tested for SARS-CoV-2 and influenza by real-time polymerase chain reaction at the central laboratory. Data from all patients with coinfection were obtained, and descriptive data analysis was performed for patients' demographics, clinical course, and outcome.

Results: The total number of patients enrolled between January 2020 and April 2022 was 18,160 and 6,453 (35.5%) tested positive for viruses, including 52 (0.8%) coinfection. Of them, 36 (69.2%) were coinfected with Flu A/H3, 9 (17.3%) Flu-B, and 7 (13.5%) Flu A/H1. Patients' mean age was 33.2 ± 21, 55.8% were males, and 20 (38.5%) were hospitalized, with mean hospital days 6.7 ± 6. At the hospital, 14 (70.0%) developed pneumonia, 6 (30.0%) ICU admitted, and 4 (20.0%) died. The hospitalization rate among patients coinfected with Flu-B and Flu A/H3 was 55.6 and 41.7%, with mean hospital days (8.0 ± 6 and 6.4 ± 6), pneumonia infection (40.0 and 80.0%), ICU admission (40.0 and 26.7%), and death (20.0% for both), while no patients hospitalized with A/H1.

Conclusions: The recent increase in the number of SARS-CoV-2/Flu coinfections was identified in Egypt. The disease could have a severe course and high fatality, especially in those coinfected with Flu-B and Flu A/H3. Monitoring disease severity and impact is required to guide preventive strategy.

背景:流感(Flu)和严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)(SARS-CoV-2/Flu)的混合感染是一个公共卫生问题,因为它可能会加重冠状病毒疾病的严重程度并增加致死率。最近有报道称,合并感染的患者人数有所增加。我们研究了在埃及急性呼吸道感染综合监测中心就诊的 SARS-CoV-2/Flu 合并感染患者的流行病学、严重程度和预后,以更好地描述疾病的影响并指导有效的预防措施:每天接诊前两名门诊病人,19 家哨点医院每五名有呼吸道症状的住院病人中选取一名作为调查对象。使用标准化问卷对患者进行访谈,并提供鼻咽拭子,在中心实验室通过实时聚合酶链反应对 SARS-CoV-2 和流感进行检测。我们获得了所有合并感染患者的数据,并对患者的人口统计学特征、临床过程和结果进行了描述性数据分析:2020年1月至2022年4月期间入组的患者总数为18160人,6453人(35.5%)病毒检测呈阳性,包括52人(0.8%)合并感染。其中,36 人(69.2%)合并感染流感 A/H3,9 人(17.3%)合并感染流感 B,7 人(13.5%)合并感染流感 A/H1。患者的平均年龄为 33.2 ± 21 岁,55.8% 为男性,20 人(38.5%)住院治疗,平均住院天数为 6.7 ± 6 天。住院期间,14 人(70.0%)患肺炎,6 人(30.0%)住进重症监护室,4 人(20.0%)死亡。同时感染流感 B 和流感 A/H3 的患者的住院率分别为 55.6% 和 41.7%,平均住院天数分别为 8.0 ± 6 天和 6.4 ± 6 天,感染肺炎的比例分别为 40.0% 和 80.0%,入住重症监护室的比例分别为 40.0% 和 26.7%,死亡的比例分别为 20.0%,而感染 A/H1 的患者均未住院:结论:在埃及,SARS-CoV-2/流感并发感染的人数近期有所增加。结论:埃及最近发现 SARS-CoV-2/流感并发感染的人数有所增加,这种疾病的病程严重,致死率高,尤其是那些同时感染流感 B 和流感 A/H3 的患者。需要监测疾病的严重程度和影响,以指导预防战略。
{"title":"Epidemiology, Disease Severity and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Viruses Coinfection Seen at Egypt Integrated Acute Respiratory Infections Surveillance, 2020-2022.","authors":"Manal Fahim, Wael H Roshdy, Ola Deghedy, Reham Kamel, Amel Naguib, Shymaa Showky, Nancy Elguindy, Mohammad Abdel Fattah, Salma Afifi, Amira Mohsen, Amr Kandeel, Khaled Abdelghaffar","doi":"10.1155/2022/7497500","DOIUrl":"10.1155/2022/7497500","url":null,"abstract":"<p><strong>Background: </strong>Cocirculation of influenza (Flu) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (SARS-CoV-2/Flu) represent a public health concern as it may worsen the severity and increase fatality from coronavirus disease 2019. An increase in the number of patients with coinfection was recently reported. We studied epidemiology, severity, and outcome of patients with SARS-CoV-2/Flu coinfection seen at Egypt's integrated acute respiratory infections surveillance to better describe disease impact and guide effective preventive measures.</p><p><strong>Methods: </strong>The first two outpatients were seen daily, and every fifth patient admitted to 19 sentinel hospitals with respiratory symptoms was enrolled. Patients were interviewed using a standardized questionnaire and provided nasopharyngeal swabs to be tested for SARS-CoV-2 and influenza by real-time polymerase chain reaction at the central laboratory. Data from all patients with coinfection were obtained, and descriptive data analysis was performed for patients' demographics, clinical course, and outcome.</p><p><strong>Results: </strong>The total number of patients enrolled between January 2020 and April 2022 was 18,160 and 6,453 (35.5%) tested positive for viruses, including 52 (0.8%) coinfection. Of them, 36 (69.2%) were coinfected with Flu A/H3, 9 (17.3%) Flu-B, and 7 (13.5%) Flu A/H1. Patients' mean age was 33.2 ± 21, 55.8% were males, and 20 (38.5%) were hospitalized, with mean hospital days 6.7 ± 6. At the hospital, 14 (70.0%) developed pneumonia, 6 (30.0%) ICU admitted, and 4 (20.0%) died. The hospitalization rate among patients coinfected with Flu-B and Flu A/H3 was 55.6 and 41.7%, with mean hospital days (8.0 ± 6 and 6.4 ± 6), pneumonia infection (40.0 and 80.0%), ICU admission (40.0 and 26.7%), and death (20.0% for both), while no patients hospitalized with A/H1.</p><p><strong>Conclusions: </strong>The recent increase in the number of SARS-CoV-2/Flu coinfections was identified in Egypt. The disease could have a severe course and high fatality, especially in those coinfected with Flu-B and Flu A/H3. Monitoring disease severity and impact is required to guide preventive strategy.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2022 ","pages":"7497500"},"PeriodicalIF":2.6,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691288/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10790005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Comparative Analysis of Two RT-qPCR Kits for Detecting SARS-CoV-2 Reveals a Higher Risk of False-Negative Diagnosis in Samples with High Quantification Cycles for Viral and Internal Genes. 用于检测 SARS-CoV-2 的两种 RT-qPCR 试剂盒的比较分析表明,病毒基因和内部基因定量周期较高的样本出现假阴性诊断的风险较高。
IF 2.6 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2022-07-05 eCollection Date: 2022-01-01 DOI: 10.1155/2022/2594564
Roberto Luraschi, Carlos Barrera-Avalos, Eva Vallejos-Vidal, Javiera Alarcón, Andrea Mella-Torres, Felipe Hernández, Ailen Inostroza-Molina, Daniel Valdés, Mónica Imarai, Claudio Acuña-Castillo, Felipe E Reyes-López, Ana María Sandino

The early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the real-time quantitative polymerase chain reaction (RT-qPCR) as a gold-standard molecular tool has allowed to test and trace the viral spread and the isolation of COVID-19-infected patients. The detection capacity of viral and internal genes is an essential parameter to consider and analyze during the assay. In this study, we analyze the performance of the two commercial RT-qPCR kits used in Chile, TaqMan™ 2019-nCoV Control Kit v1 (Thermo Fisher) and MaxCov19 (TAAG Genetics), for the COVID-19 diagnosis from nasopharyngeal swab samples (NPSs). Our results show a lower sensitivity of the TAAG kit compared to the Thermo Fisher kit, even in the detection of SARS-CoV-2 mutations associated with its variants. This study reinforces the relevance of evaluating the performance of RT-qPCR kits before being used massively since those with lower sensitivity can generate false negatives and produce outbreaks of local infections.

使用实时定量聚合酶链式反应(RT-qPCR)这一黄金标准分子工具对严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)进行早期检测,可以检测和追踪病毒传播情况以及 COVID-19 感染者的分离情况。病毒基因和内部基因的检测能力是检测过程中需要考虑和分析的重要参数。在本研究中,我们分析了智利使用的两种商用 RT-qPCR 试剂盒(TaqMan™ 2019-nCoV Control Kit v1 (Thermo Fisher) 和 MaxCov19 (TAAG Genetics))在从鼻咽拭子样本(NPS)诊断 COVID-19 方面的性能。我们的结果表明,与赛默飞世尔试剂盒相比,TAAG 试剂盒的灵敏度较低,甚至在检测与变异体相关的 SARS-CoV-2 突变时也是如此。这项研究强调了在大规模使用 RT-qPCR 试剂盒之前对其性能进行评估的重要性,因为灵敏度较低的试剂盒可能会产生假阴性,并导致局部感染的爆发。
{"title":"The Comparative Analysis of Two RT-qPCR Kits for Detecting SARS-CoV-2 Reveals a Higher Risk of False-Negative Diagnosis in Samples with High Quantification Cycles for Viral and Internal Genes.","authors":"Roberto Luraschi, Carlos Barrera-Avalos, Eva Vallejos-Vidal, Javiera Alarcón, Andrea Mella-Torres, Felipe Hernández, Ailen Inostroza-Molina, Daniel Valdés, Mónica Imarai, Claudio Acuña-Castillo, Felipe E Reyes-López, Ana María Sandino","doi":"10.1155/2022/2594564","DOIUrl":"10.1155/2022/2594564","url":null,"abstract":"<p><p>The early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the real-time quantitative polymerase chain reaction (RT-qPCR) as a gold-standard molecular tool has allowed to test and trace the viral spread and the isolation of COVID-19-infected patients. The detection capacity of viral and internal genes is an essential parameter to consider and analyze during the assay. In this study, we analyze the performance of the two commercial RT-qPCR kits used in Chile, TaqMan™ 2019-nCoV Control Kit v1 (Thermo Fisher) and MaxCov19 (TAAG Genetics), for the COVID-19 diagnosis from nasopharyngeal swab samples (NPSs). Our results show a lower sensitivity of the TAAG kit compared to the Thermo Fisher kit, even in the detection of SARS-CoV-2 mutations associated with its variants. This study reinforces the relevance of evaluating the performance of RT-qPCR kits before being used massively since those with lower sensitivity can generate false negatives and produce outbreaks of local infections.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2022 ","pages":"2594564"},"PeriodicalIF":2.6,"publicationDate":"2022-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10632643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation. 囊性纤维化肺加重患者分离细菌的分布和特点。
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2022-01-01 DOI: 10.1155/2022/5831139
Soroor Erfanimanesh, Mohammad Emaneini, Mohammad Reza Modaresi, Mohammad Mehdi Feizabadi, Shahnaz Halimi, Reza Beigverdi, Vajiheh Sadat Nikbin, Fereshteh Jabalameli

Background: Cystic fibrosis (CF) is an inherited recessive disorder characterized by recurrent and persistent pulmonary infections, resulting in lung function deterioration and early mortality.

Methods: A cross-sectional study was conducted on the bacterial profile and antibiotic resistance pattern of 103 respiratory specimens from CF patients with signs of pulmonary exacerbation. Antibiotic susceptibility testing and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa isolates were performed by the Kirby-Bauer disc diffusion method and microtiter plate assay, respectively. Molecular typing of S. aureus and P. aeruginosa isolates was carried out by spa typing and repetitive extragenic palindromic element PCR.

Results: In a total of 129 isolates, the most prevalent organisms were S. aureus (55.3%) and P. aeruginosa (41.7%). Other less prevalent bacterial isolates include coagulase-negative staphylococci, Escherichia coli, klebsiella spp., Enterobacter spp., and Achromobacter xylosoxidans. The highest rate of resistance for S. aureus was observed to azithromycin and erythromycin (80%), ciprofloxacin (52.3%), clindamycin (44.6%) and tetracycline (43%). Twenty percent of S. aureus isolates were methicillin-resistant S. aureus (MRSA) and 47.6% were MDR S. aureus. For P. aeruginosa isolates the highest resistance was to cefepime (38.3%) and levofloxacin (33.3%) and 20% showed MDR phenotype.

Conclusion: Our study demonstrated a significant decline in the prevalence of P. aeruginosa infections in comparison to previous studies. We found S. aureus to be more prevalent in younger patients, whereas mucoid P. aeruginosa showed a shift in prevalence toward older ages. Molecular typing methods showed great diversity between isolates.

背景:囊性纤维化(CF)是一种以复发性和持续性肺部感染为特征的遗传性隐性疾病,可导致肺功能恶化和早期死亡。方法:对103例有肺加重症状的CF患者呼吸道标本的细菌谱和抗生素耐药模式进行横断面研究。采用Kirby-Bauer圆盘扩散法和微滴板法分别对金黄色葡萄球菌和铜绿假单胞菌进行抗生素药敏试验和生物膜形成试验。采用spa分型和重复基因外回文元件PCR对金黄色葡萄球菌和铜绿假单胞菌进行分子分型。结果:129株分离菌中以金黄色葡萄球菌(55.3%)和铜绿假单胞菌(41.7%)最常见。其他不太常见的细菌分离物包括凝固酶阴性葡萄球菌、大肠杆菌、克雷伯氏菌、肠杆菌和木氧化无色杆菌。金黄色葡萄球菌对阿奇霉素和红霉素的耐药率最高(80%),其次是环丙沙星(52.3%)、克林霉素(44.6%)和四环素(43%)。金黄色葡萄球菌中20%为耐甲氧西林金黄色葡萄球菌(MRSA), 47.6%为耐多药金黄色葡萄球菌。铜绿假单胞菌对头孢吡肟(38.3%)和左氧氟沙星(33.3%)的耐药最高,20%表现为耐多药表型。结论:我们的研究表明,与以前的研究相比,铜绿假单胞菌感染的患病率显著下降。我们发现金黄色葡萄球菌在年轻患者中更普遍,而粘液样铜绿假单胞菌在年龄较大的患者中患病率有所变化。分子分型方法显示菌株间存在很大差异。
{"title":"Distribution and Characteristics of Bacteria Isolated from Cystic Fibrosis Patients with Pulmonary Exacerbation.","authors":"Soroor Erfanimanesh,&nbsp;Mohammad Emaneini,&nbsp;Mohammad Reza Modaresi,&nbsp;Mohammad Mehdi Feizabadi,&nbsp;Shahnaz Halimi,&nbsp;Reza Beigverdi,&nbsp;Vajiheh Sadat Nikbin,&nbsp;Fereshteh Jabalameli","doi":"10.1155/2022/5831139","DOIUrl":"https://doi.org/10.1155/2022/5831139","url":null,"abstract":"<p><strong>Background: </strong>Cystic fibrosis (CF) is an inherited recessive disorder characterized by recurrent and persistent pulmonary infections, resulting in lung function deterioration and early mortality.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on the bacterial profile and antibiotic resistance pattern of 103 respiratory specimens from CF patients with signs of pulmonary exacerbation. Antibiotic susceptibility testing and biofilm formation of <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i> isolates were performed by the Kirby-Bauer disc diffusion method and microtiter plate assay, respectively. Molecular typing of <i>S. aureus</i> and <i>P. aeruginosa</i> isolates was carried out by spa typing and repetitive extragenic palindromic element PCR.</p><p><strong>Results: </strong>In a total of 129 isolates, the most prevalent organisms were <i>S. aureus</i> (55.3%) and <i>P. aeruginosa</i> (41.7%). Other less prevalent bacterial isolates include coagulase-negative staphylococci, <i>Escherichia coli</i>, <i>klebsiella spp.</i>, <i>Enterobacter spp.</i>, and <i>Achromobacter xylosoxidans</i>. The highest rate of resistance for <i>S. aureus</i> was observed to azithromycin and erythromycin (80%), ciprofloxacin (52.3%), clindamycin (44.6%) and tetracycline (43%). Twenty percent of <i>S. aureus</i> isolates were methicillin-resistant <i>S. aureus</i> (MRSA) and 47.6% were MDR <i>S. aureus</i>. For <i>P. aeruginosa</i> isolates the highest resistance was to cefepime (38.3%) and levofloxacin (33.3%) and 20% showed MDR phenotype.</p><p><strong>Conclusion: </strong>Our study demonstrated a significant decline in the prevalence of <i>P. aeruginosa</i> infections in comparison to previous studies. We found <i>S. aureus</i> to be more prevalent in younger patients, whereas mucoid <i>P. aeruginosa</i> showed a shift in prevalence toward older ages. Molecular typing methods showed great diversity between isolates.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2022 ","pages":"5831139"},"PeriodicalIF":2.8,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9184501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Prevalence and Antibiotics Susceptibility Patterns of Corynebacterium minutissimum Isolates from Skin Lesions of Patients with Suspected Erythrasma from Tabriz, Iran. 伊朗大不里士地区疑似红斑患者皮损中微小棒状杆菌的流行及抗生素敏感性分析。
IF 2.8 4区 医学 Q3 INFECTIOUS DISEASES Pub Date : 2022-01-01 DOI: 10.1155/2022/4016173
Seyedeh Zahra Salemi, Mohammad Yousef Memar, Hossein Samadi Kafil, Javid Sadeghi, Hamideh Herizchi Ghadim, Hamideh Azimi Alamdari, Javad Nezhadi, Reza Ghotaslou

Erythrasma is a chronic infection of the skin that appears in the body folds as flat copper spots. The causative agent of this infection is Corynebacterium minutissimum (C. minutissimum). Erythrasma can be treated with antiseptics or topical antibiotics. The study aimed to investigate the antibiotics susceptibility patterns, and the presence of the erythromycin resistance gene (ermX and mefA) in C. minutissimum isolates in skin lesions with suspected erythrasma. From July 2020 to May 2022, 278 skin scrub specimens were collected from patients admitted to the hospital of Tabriz University of Medical Sciences. Specimens were incubated on the blood agar plates and isolates were identified by microbiological laboratory methods. The antibiotic susceptibility patterns were determined by the disk diffusion method and resistance genes of ermX and mefA were detected by the PCR method. Out of 278 specimens, 41 C. minutissimum isolates (14.74%) were recovered. The highest frequency of resistance was observed to a penicillin (75.6%) followed by erythromycin and clarithromycin (39.02%), clindamycin (30.05%), tetracycline (24.2%), and gentamicin and neomycin (19.5%). The frequencies of ermX and mefA genes were 75% and 12.5%, respectively. Resistance to antimicrobial drugs was common and worrying. Resistance to erythromycin in C. minutissimum is mainly related to the ermX gene.

红斑是一种慢性皮肤感染,在身体褶皱处出现扁平的铜斑。这种感染的病原体是微小棒状杆菌(C. minutissimum)。红斑可以用防腐剂或局部抗生素治疗。本研究旨在探讨疑似红斑皮损的微小C. mintissimum分离株的抗生素药敏模式及红霉素耐药基因(ermX和mefA)的存在。从2020年7月至2022年5月,从大不里士医科大学医院收治的患者中采集278份皮肤擦洗标本。标本在血琼脂平板上孵育,分离物用微生物实验室方法鉴定。采用纸片扩散法测定菌株的药敏模式,采用PCR法检测菌株ermX和mefA的耐药基因。278份标本中,分离出41株微小弧菌(14.74%)。耐药频率最高的是青霉素(75.6%),其次是红霉素和克拉霉素(39.02%)、克林霉素(30.05%)、四环素(24.2%)和庆大霉素和新霉素(19.5%)。ermX和mefA基因的频率分别为75%和12.5%。抗微生物药物耐药性普遍存在,令人担忧。小锥虫对红霉素的耐药主要与ermX基因有关。
{"title":"The Prevalence and Antibiotics Susceptibility Patterns of <i>Corynebacterium minutissimum</i> Isolates from Skin Lesions of Patients with Suspected Erythrasma from Tabriz, Iran.","authors":"Seyedeh Zahra Salemi,&nbsp;Mohammad Yousef Memar,&nbsp;Hossein Samadi Kafil,&nbsp;Javid Sadeghi,&nbsp;Hamideh Herizchi Ghadim,&nbsp;Hamideh Azimi Alamdari,&nbsp;Javad Nezhadi,&nbsp;Reza Ghotaslou","doi":"10.1155/2022/4016173","DOIUrl":"https://doi.org/10.1155/2022/4016173","url":null,"abstract":"<p><p>Erythrasma is a chronic infection of the skin that appears in the body folds as flat copper spots. The causative agent of this infection is <i>Corynebacterium minutissimum</i> (<i>C. minutissimum</i>). Erythrasma can be treated with antiseptics or topical antibiotics. The study aimed to investigate the antibiotics susceptibility patterns, and the presence of the erythromycin resistance gene (<i>ermX</i> and <i>mefA</i>) in <i>C. minutissimum</i> isolates in skin lesions with suspected erythrasma. From July 2020 to May 2022, 278 skin scrub specimens were collected from patients admitted to the hospital of Tabriz University of Medical Sciences. Specimens were incubated on the blood agar plates and isolates were identified by microbiological laboratory methods. The antibiotic susceptibility patterns were determined by the disk diffusion method and resistance genes of <i>ermX</i> and <i>mefA</i> were detected by the PCR method. Out of 278 specimens, 41 <i>C. minutissimum</i> isolates (14.74%) were recovered. The highest frequency of resistance was observed to a penicillin (75.6%) followed by erythromycin and clarithromycin (39.02%), clindamycin (30.05%), tetracycline (24.2%), and gentamicin and neomycin (19.5%). The frequencies of <i>ermX</i> and <i>mefA</i> genes were 75% and 12.5%, respectively. Resistance to antimicrobial drugs was common and worrying. Resistance to erythromycin in <i>C. minutissimum</i> is mainly related to the <i>ermX</i> gene.</p>","PeriodicalId":50715,"journal":{"name":"Canadian Journal of Infectious Diseases & Medical Microbiology","volume":"2022 ","pages":"4016173"},"PeriodicalIF":2.8,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10337813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Canadian Journal of Infectious Diseases & Medical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1